|
|
EQSNews: BRAIN Biotech AG
/ Key words: Personnel/Strategic Company Decision
Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand
27.09.2022 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Luka... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BRAIN Biotech AG
/ Key words: Disposal/Strategic Company Decision
BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
26.09.2022 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech AG further focusses business activities... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Quarter Results/Quarterly / Interim Statement
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
29.08.2022 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech AG: On Track to Reach Financial Y... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Sustainability
BRAIN Biotech publishes first ESG and Sustainability Report
20.06.2022 / 08:00
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech publishes first ESG and Sustainability Report
Zwingenberg, June 20, 202... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Personnel
BRAIN Biotech AG: Prof. Dr. Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasons
30.05.2022 / 09:00
The issuer is solely responsible for the content of this announcement.
Prof. Dr. Bernhard Hauer leaves Supervisory Board of BRAIN Biot... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Half Year Results/Half Year Report
BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting
30.05.2022 / 07:30
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech AG: Ongoing Dynamic Sales Development and... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Miscellaneous
BRAIN Biotech AG: Successful Genome Editing in Mammalian Cells with BRAINMetagenomeCas BMC, BRAINEngineeredCas BEC
04.04.2022 / 10:40
The issuer is solely responsible for the content of this announcement.
Successful Genome Editing in Mammalian Cells with... Lire le communiqué |
|
| |
|
| |
